Solvay Group:企業の戦略・SWOT・財務情報

◆英語タイトル:Solvay Group - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3714
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥24,150見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥48,300見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥72,450見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Solvay Group – Strategy, SWOT and Corporate Finance Report
Summary

Solvay Group – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Solvay Group (Solvay or ‘the group’), consisting of Solvay S.A. and other subsidiaries, is engaged in manufacturing and marketing of chemicals and plastic products. The group offers products such as sodium carbonate, sodium bicarbonate, hydrogen peroxide, peracetic acid cellulose acetate tow/flakes, silica, high performance polyester and aromatic polyamides. It also offers products such as phenol and derivatives, natural vanillin, surfactants, textile yarns, staple fibers among others. The group markets its products under brands such as AMNI, EMANA BicarZ, Bi-PROTEC, Cerox, Diofan, Govanil, Hyflon and IXPER. It serves customers operating in aeronautics and automotive, resources and environment, electrical and electronics, agro, feed and food, consumer goods and healthcare, building and construction, industrial applications and other sectors. The group operates in several countries in Europe, the Americas, Asia and rest of the world. Solvay is headquartered in Brussels, Belgium.

Scope

- Detailed information on Solvay Group required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Solvay Group in the form of a SWOT analysis
- An in-depth view of the business model of Solvay Group including a breakdown and examination of key business segments
- Intelligence on Solvay Group’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Solvay Group, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Solvay Group and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Solvay Group as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Solvay Group’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Solvay Group: Company Overview 9
Solvay Group: Overview and Key Facts 9
Solvay Group: Overview 9
Solvay Group: Key Facts 9
Solvay Group: Key Employees 11
Solvay Group: Key Employee Biographies 12
Solvay Group: Major Products and Services 13
Solvay Group: Company History 15
Solvay Group: Management Statement 24
Solvay Group: Locations and Subsidiaries 26
Solvay Group: Key Competitors 27
Solvay Group: Company Analysis 28
Solvay Group: Business Description 28
Solvay Group: SWOT Analysis 30
Solvay Group: SWOT Overview 30
Solvay Group: Strengths 30
Solvay Group: Weaknesses 31
Solvay Group: Opportunities 31
Solvay Group: Threats 32
Solvay Group: Corporate Financial Deals Activity 33
Solvay Group: Financial Deals Overview 33
Solvay Group: Targets and Partners 35
Solvay Group: Top Deals 2014 – 2018YTD* 36
Solvay Group: Advisors 37
Solvay Group: Top Legal Advisors 37
Solvay Group: Top Financial Advisors 37
Solvay Group: Mergers and Acquisitions 38
Solvay Group: Partnership 39
Solvay Group: Divestments 40
Solvay Group: Recent Developments 41
Solvay Group: News and Events Summary 41
Solvay Group: Business Expansion 45
Solvay Group: Contracts 45
Solvay Group: Financial Deals 46
Solvay Group: Financial Performance 47
Solvay Group: Strategy and Operations 47
Appendix 49
Contact Us 49
Methodology 49
About MarketLine 50

List of Tables
Table 1: Solvay Group: Key Facts
Table 2: Solvay Group: Key Employees
Table 3: Solvay Group: Locations and Subsidiaries
Table 4: Solvay Group: Key Competitors
Table 5: Solvay Group: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Solvay Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Solvay Group: M&A Average Deal Size - Value (US$m)
Table 8: Solvay Group: Targets and Partners
Table 9: Solvay Group: Top Deals 2014 - 2018YTD*
Table 10: Solvay Group: Legal Advisor Ranking by Value (US$m)
Table 11: Solvay Group: Financial Advisor Ranking by Value (US$m)
Table 12: Solvay Group: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Solvay Group: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Solvay Group: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 15: Solvay Group: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 16: Solvay Group: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 17: Solvay Group: Divestments by Geography (2014 - YTD*2018)
Table 18: Solvay Group: News and Events Summary
Table 19: Solvay Group: Business Expansion
Table 20: Solvay Group: Contracts
Table 21: Solvay Group: Financial Deals
Table 22: Solvay Group: Financial Performance
Table 23: Solvay Group: Strategy and Operations

List of Figures
Figure 1: Solvay Group: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Solvay Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Solvay Group: M&A Average Deal Size - Value (US$m)
Figure 4: Solvay Group: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Solvay Group: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Solvay Group: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Solvay Group: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 8: Solvay Group: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 9: Solvay Group: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Solvay Group:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HTL International Holdings Limited:企業の戦略的SWOT分析
    HTL International Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • CITIC Resources Holdings Limited:戦略・SWOT・企業財務分析
    CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Chevron Nigeria Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Nigeria Ltd (Chevron Nigeria) a subsidiary of Chevron Corporation is an oil and gas company that offers exploration, production and transportation of crude oil and natural gas. The company distributes products such as additives, jet fuels, base oil, chemical, fuel, lubricant, marine …
  • Zocere Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zocere Inc (Zocere), formerly Tyrosine Pharmaceuticals Inc is a biotechnology company that develops novel therapeutics for neurological diseases. The company offers services to support the pharmaceutical and biotechnology fields developing stroke-related diagnostics and treatments. Its drugs …
  • Shanghai Kehua Bio-engineering Co Ltd (002022):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, ch …
  • Boston Scientific Corp (BSX):企業の財務・戦略的SWOT分析
    Boston Scientific Corp (BSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ZTE Corp:企業の戦略・SWOT・財務情報
    ZTE Corp - Strategy, SWOT and Corporate Finance Report Summary ZTE Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Sequential Brands Group, Inc.:企業のM&A・事業提携・投資動向
    Sequential Brands Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sequential Brands Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Memry Corp:企業の戦略的SWOT分析
    Memry Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Infinity Pharmaceuticals Inc (INFI):製薬・医療:M&Aディール及び事業提携情報
    Summary Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company that discovers and develops small molecule therapeutics for the treatment of cancer. The company’s pipeline candidate: IPI-549 selectively inhibits PI3K-gamma to reprogram tumor-associated macrophages and …
  • Sunshine Biopharma Inc (SBFM):企業の財務・戦略的SWOT分析
    Summary Sunshine BioPharma Inc (Sunshine BioPharma), a subsidiary of Advanomics Corp is a pharmaceutical company that offers research, development and commercialization of drugs for treating cancer disease. The company provides generic and proprietary drugs for the treatment of cancer and other acut …
  • Bulgarian Energy Holding EAD:企業の戦略的SWOT分析
    Bulgarian Energy Holding EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Washington State University-製薬・医療分野:企業M&A・提携分析
    Summary Washington State University (WSU) is an educational university that provides educational and research programs. The university offers undergraduate, graduate, professional, international and online courses. It provides educational programs in the areas of agricultural, environmental and natu …
  • Canara Bank:企業の戦略・SWOT・財務分析
    Canara Bank - Strategy, SWOT and Corporate Finance Report Summary Canara Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Ambrx Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ambrx Inc (Ambrx) is a biopharmaceutical company that offers discovery and development of protein-based medicines by using its expanded genetic code. The company provides pipeline product candidate’s portfolio such as ARX618 FGF21, PSMA ADC, CD70 ADC and Anti-CD3 X Folate. It develops pipeli …
  • Societe Generale S.A.:企業の戦略・SWOT・財務情報
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • FirstCaribbean International Bank Limited:企業の戦略的SWOT分析
    FirstCaribbean International Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • HemaCare Corp (HEMA):企業の財務・戦略的SWOT分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, cord blood, and bone marrow. It spans its expertise in isolations, custom cell collections and testing of p …
  • Canadian Cancer Trials Group-製薬・医療分野:企業M&A・提携分析
    Summary Canadian Cancer Trials Group (CCTG), formerly known as NCIC Clinical Trials Group, is a subsidiary of Cancer Research Institute at Queen's University, is a contract research organization that conducts clinical trials. The organization conducts trials for the development of new drugs and ther …
  • Eli Lilly and Co (LLY):医療機器:M&Aディール及び事業提携情報
    Summary Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. It als …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆